Method for treating HIV with chlorine dioxide and a phosphate compound
AssigneeVortech, Inc.
InventorPerry A. Ratcliff
Life of this patent
Estimating the term…
Loading patent…
AssigneeVortech, Inc.
InventorPerry A. Ratcliff
Estimating the term…
A method and solution or gel composition containing activated chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for lubricating the vagina and for treating HIV. The preferred concentration ranges are between about 0.005% to about 2.0% chlorine dioxide, and between about 0.02% to about 3.0% phosphate. The phosphate compound retards escape of chlorine dioxide in the pH range of about 6.0 to 7.4, at which pH the chlorine dioxide becomes activated and releases sufficient chlorine dioxide to reduce motility and become lethal to the involved micro-organisms.
A method for treating HIV, said method consists of the step of applying to the vagina and adnexa a topical preparation selected from the group consisting of liquid solutions, suspensions, semi-solids, salves, creams, gels, and suppositories, wherein said topical preparation consists of by volume about 12.0% gylcerine, about 1.0% hydroxyethyl cellulose, about 0.6% glucono delta lactone, about 0.1% chlorine dioxide in deionized water and about 0.05% of a phosphate compound.
Dependencies are inferred from the claim text.